DeepMed Research

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone

Active, not recruiting

Conditions: Pediatric Growth Hormone Deficiency

Interventions: Drug: Ngenla

First Posted Date: 2022-08-22

Last Posted Date: 2025-05-18

Lead Sponsor: Pfizer

Target Recruit Count: 565

Registration Number: NCT05509894

Locations: 🇰🇷
Pfizer, Seoul, Korea, Republic of

Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC

Completed

Conditions: Breast Cancer
Breast Carcinoma

First Posted Date: 2022-08-17

Last Posted Date: 2023-05-25

Lead Sponsor: Pfizer

Target Recruit Count: 120

Registration Number: NCT05505175

Locations: 🇧🇷
NOB - Nucleo de Oncologia da Bahia, Salvador, Bahia, Brazil
🇧🇷
Oncoclínicas Do Brasil Servicos Médicos S/A - Oncocentro, Belo Horizonte, Minas Gerais, Brazil
🇧🇷
Ensino E Terapia de Inovação Clínica Amo - Ética, Salvador, Bahia, Brazil

and more 11 locations

A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Tafamidis free acid tablet (Test)
Drug: Tafamidis meglumine capsule (Reference)

First Posted Date: 2022-08-12

Last Posted Date: 2024-06-03

Lead Sponsor: Pfizer

Target Recruit Count: 22

Registration Number: NCT05498701

Locations: 🇨🇦
Pharma Medica Research Inc, Toronto, Ontario, Canada

A Preliminary Study to Evaluate PF-07264660 in Healthy Participants

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-07264660 subcutaneous multiple ascending dose
Other: Intravenous placebo
Drug: PF-07264660 intravenous single ascending dose
Other: subcutaneous placebo

First Posted Date: 2022-08-11

Last Posted Date: 2024-06-06

Lead Sponsor: Pfizer

Target Recruit Count: 59

Registration Number: NCT05496738

Locations: 🇺🇸
Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, United States
🇺🇸
Spaulding Clinical Research, West Bend, Wisconsin, United States
🇺🇸
Collaborative Neuroscience Research, LLC, Los Alamitos, California, United States

and more 1 locations

A Study of Ponsegromab in People With Heart Failure

Phase 2

Terminated

Conditions: Heart Failure

First Posted Date: 2022-08-08

Last Posted Date: 2025-05-20

Lead Sponsor: Pfizer

Target Recruit Count: 456

Registration Number: NCT05492500

Locations: 🇨🇿
Vseobecna fakultni nemocnice v Praze, Praha 2, Czechia
🇨🇿
Ustredni vojenska nemocnice, Praha 6, Czechia
🇩🇪
Universitätsklinikum Frankfurt Goethe-Universität, Frankfurt, Hessen, Germany

and more 118 locations

Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

Phase 1

Completed

Conditions: Pneumococcal Disease

Interventions: Other: Candidate-4
Biological: 13vPnC
Other: Candidate-2
Other: Candidate-3
Other: Candidate-5
Other: Candidate Control
Biological: PCV15
Other: Candidate-1
Other: Candidate-6

First Posted Date: 2022-08-05

Last Posted Date: 2024-04-18

Lead Sponsor: Pfizer

Target Recruit Count: 394

Registration Number: NCT05489328

Locations: 🇺🇸
DM Clinical Research, Tomball, Texas, United States
🇺🇸
Orange County Research Center, Tustin, California, United States
🇺🇸
Indago Research & Health Center, Inc, Hialeah, Florida, United States

and more 15 locations

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Phase 1

Terminated

Conditions: COVID-19

Interventions: Drug: PF-07321332 (nirmatrelvir)/ritonavir

First Posted Date: 2022-08-04

Last Posted Date: 2024-05-23

Lead Sponsor: Pfizer

Target Recruit Count: 15

Registration Number: NCT05487040

Locations: 🇺🇸
Fresenius Kidney Care-Meridian, Meridian, Idaho, United States
🇺🇸
NorthShore University HealthSystem - Glenbrook Hospital, Glenview, Illinois, United States
🇺🇸
Fresenius Kidney Care Huntsville, Huntsville, Alabama, United States

and more 49 locations

A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting

Completed

Conditions: Arthritis, Rheumatoid

First Posted Date: 2022-08-04

Last Posted Date: 2024-10-07

Lead Sponsor: Pfizer

Target Recruit Count: 318

Registration Number: NCT05487703

Locations: 🇲🇦
Pfizer, Casablanca, Morocco

Real-World Study of Ceftazidime Avibactam in China

Recruiting

Conditions: Hospital Acquired Pneumonia
Ventilator Acquired Pneumonia
Complicated Intra Abdominal Infections

Interventions: Drug: ceftazidime avibactam group

First Posted Date: 2022-08-04

Last Posted Date: 2024-08-23

Lead Sponsor: Pfizer

Target Recruit Count: 450

Registration Number: NCT05487586

Locations: 🇨🇳
The Second People's Hospital of Hebei Medical University, Shijiazhuang, China
🇨🇳
Huashan Hospital Fudan University, Shanghai, Shanghai, China
🇨🇳
Beijing Tsinghua Changgung Hospital, Beijing, China

and more 14 locations

A Study to Compare Two Tablet Forms of Tafamidis in Healthy Participants

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Tafamidis free acid tablet (Test)
Drug: Tafamidis free acid tablet (Reference)

First Posted Date: 2022-08-01

Last Posted Date: 2024-05-23

Lead Sponsor: Pfizer

Target Recruit Count: 12

Registration Number: NCT05482308

Locations: 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy